Next-Gen ddPCR Oncology Assays

About Bio-Rad

Bio-Rad Laboratories operates a resilient, dual-segment business model spanning Life Science research tools and Clinical Diagnostics systems. The company has established a formidable competitive moat through its proprietary Droplet Digital PCR (ddPCR) technology, which has become a gold standard for high-sensitivity nucleic acid quantification. Its strategy focuses on providing essential, high-value tools that drive discovery and ensure diagnostic accuracy, balancing exposure to research funding cycles with the stable, regulated diagnostics market. With a 70+ year history, Bio-Rad is a foundational, publicly traded entity in the global biotech and healthcare infrastructure.

Therapeutic Areas